WELLINGTON MANAGEMENT CO LLP 13D and 13G filings for United Therapeutics Corporation:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-02-10 10:25 am Sale |
2024-12-31 | 13G | United Therapeutics Corporation UTHR |
WELLINGTON MANAGEMENT CO LLP | 2,463,891 5.500% |
-1,330,119 (-35.06%) |
Filing |
| 2024-02-08 10:18 am Sale |
2023-12-29 | 13G | United Therapeutics Corporation UTHR |
WELLINGTON MANAGEMENT CO LLP | 3,794,010 8.070% |
-894,814 (-19.08%) |
Filing |
| 2023-07-10 08:44 am Purchase |
2023-06-30 | 13G | United Therapeutics Corporation UTHR |
WELLINGTON MANAGEMENT CO LLP | 4,688,824 10.010% |
2,119,561 (+82.50%) |
Filing |
| 2023-02-06 2:58 pm Purchase |
2022-12-30 | 13G | United Therapeutics Corporation UTHR |
WELLINGTON MANAGEMENT CO LLP | 2,569,263 5.640% |
2,569,263 (New Position) |
Filing |